Notifications
Back
About
WAYCEN
A Leader in Med Tech
AI technology that saves lives.
A company specialized in medical AI, 
is used in the medical sites beyond a world-class level of AI technology
and is moving forward to develop AI technology that can save lives.
Our Mission
We research AI MEDTECH technology used in medical environments 
based on the best AI technology in the world. 
WAYCEN is devoting itself to creating artificial intelligence solutions that are essential and applicable
 to the medical environment under the slogan of AI (Applicable Innovation) beyond AI (Artificial Intelligence).
Quick facts
WAYCEN is growing rapidly based on sound technology. 

Domestic/foreign patents



 +





Research cooperative hospitals



 +





AI medical research task experience



 +





AI medical research experts ratio



 +





%


Domestic/foreign patents


 +





Research cooperative hospitals


 +





AI medical research task experience


 +





AI medical research experts ratio


 +





%


Our History
2023
2023
07
WAYMED Endo gets designated as 37th Breakthrough medical device 
05
Supplied WAYMED Endo to Gangneung Asan Hospital 
05
Selected for Nvidia Startup Incubation Program (N-UP) 
05
Selected as a future unicorn company by Ministry of Science and ICT 
04
Achieved 3rd Class Medical Device Certification (KFDA) for WAYMED Endo 
03
Awarded by the Minister of Health and Welfare 
01
Won 4 awards at CES 2023 Innovation Awards 
2022
2022
01
Won CES innovation Awards 2022 Health&Wellness 
01
Achieved Second rank in WAYMED endo(stomach/intestine)
2021
2021
07
Selected as material parts equipment heterogeneous technology fusion conducted by Korea Evaluation Institute of Industrial Technology
07
WAYCEN-Kangbuk Samsung Hospital, AI-based chronic disease care plan joint research 
07
Selected for Microsoft Startup Program 
06
Selected as one of 'Seoul Metropolitan City's 4 Promising Leading Companies in the Future Growth Industry' 
05
Selected as 'Baby Unicorn' by the Ministry of Venture Business and the Korea Institute of Startup & Entrepreneurship 
05
Selected as a final company in the Microsoft Startup Program 
04
Gangnam Severance Hospital, KAIST Genetic Consensus Incubator Project Group, and WAYCEN 3-party AI-based Medical Big Data Technology Joint Research Agreement 
03
Won order to develop a digital treatment for curing diseases of the brain from the National Research Foundation of Korea. 
03
Korea University Guro Hospital Emergency Medicine Department Medical AI Joint Research 
02
Series A investment attraction 
2020
2020
12
Acquired Certificate of Conformity for Medical Device Manufacturing and Quality Control (Clinical GMP)  
12
Joint research on medical AI in orthopedic surgery at Asan Medical Center, Seoul
11
Sinchon Severance Hospital joint research on Medical AI in respiratory medicine   
09
Concluded Vietnam business cooperation contract with JK Partners in Vietnam  
09
Concluded joint research cooperation contract with the KAIST Gene Donguibogam Project  
07
Selected as a TIPS-linked business (start-up commercialization, overseas marketing business) 
05
Selected as the 2020 TIPS Startup Team - Hosted by the Small and Medium Business Administration   
03
Venture Business Certification 
03
Selected as a 2020 SW High Growth Preliminary Company - Hosted by NIPA Ministry of Science and Technology
03
Joint research on medical AI with the Department of Pediatrics and Adolescents at Korea University Guro Hospital 
02
Infobank Private Investment Association No. 1 Investment Attraction
02
Established corporate research institute 
2019
2019
07
Established WAYCEN 
Pipeline

Our Partners & Collaborators

5th floor, 524 Samseong-ro (Saehwa Building), Gangnam-gu, Seoul
TEL  +82-2-588-0863    l    FAX  +82-2-588-0862 
contcat@waycen.com  marketing@waycen.com 
ⓒ Waycen Inc. ALL RIGHTS RESERVED